FDA warns sanitizer firms on MRSA claims; Roche sues Sandoz over generic Valcyte;

@FiercePharma: J&J defends executive pay to institutional investors. News | Follow @FiercePharma

> The FDA issued four warning letters to companies that market over-the-counter drug products, including hand sanitizers, that claim to prevent infection from methicillin-resistant Staphylococcus aureus bacteria (MRSA). FDA release

> Roche's Genentech unit has sued Sandoz for planning to sell a generic version of Valcyte, which treats a virus that afflicts transplant patients and people with AIDS, before Genentech's patent expires. News

> Watson Pharmaceuticals is challenging Daiichi Sankyo's patent on the cholesterol drug Welchol to clear the way for a sale of a generic version. Story

> The Obama administration urged a federal judge to dismiss a lawsuit that challenged a decision to allow unapproved drugs to be imported for use in executions of death row inmates. Item

> Eisai's sea sponge-derived breast cancer drug Halaven has been launched in the UK following approval from European regulators a month ago. Article

> The new owner of Genzyme's former genetics testing business plans to eliminate 169 jobs at its Westborough site this year and next, according to a memo circulated last week. Report

> Mylan has started selling a generic version of the Novartis antiviral drug Famvir. News

> Covidien reported a higher-than-expected quarterly profit, helped by strong demand for its medical devices, while pharma sells fell by four percent to $490 million. Item

Biotech News

 @FierceBiotech: Sangart raises $50M to fund critical Ph2b ischemia study. Report | Follow @FierceBiotech

 @JohnCFierce: Janssen dumps antibiotic pact as it shifts out of the field, focuses on vaccines. Report | Follow @JohnCFierce

> Dissidents say Actelion battle will hinge on institutional investors. Story

> Valeant offers a stick, a carrot and a May 12 deadline to Cephalon investors. Article 

> VC report: Rounds get fatter as the number of deals shrinks. News 

Vaccines News

> NanoBio pursues nasal vaccine to prevent UTIs. Report 

> Report: GlaxoSmithKline in talks to buy India vaccine unit. Item 

> Novavax gets a new CEO. News 

> Inovio, Transgene and ChronTech enter HepC pact. Article 

> Aduro licenses BioSante cancer vaccines. Story 

Manufacturing News

> Hamburg pushes science, enforcement in FDA strategy. News 

> J&J quantifies manufacturing woes in financials. Article  

> Pfizer plant prepped before demolition to contain killer API. Item 

> FDA director offers QbD insight. Story 

> Reddy: Process expertise, luck drove success. News 

> U.S. plants fall to GSK strategy shift. Article 

And Finally... Small doses of aspirin can lower the risk of heart attacks in people who never had heart disease, but the blood-thinning drug doesn't appear to cut the chances of strokes or dying from the disease. Report